Related Experiment Videos
[Current advances and expectations in tumor immunology]
1Department of Immunology, Juntendo University School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Human Cell
|January 5, 2002
Summary
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) on natural killer (NK) cells suppresses tumor growth. This study reveals TRAIL’s physiological role in tumor suppression, mediated by IFN-gamma-activated NK cells.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Signaling
Context:
- Natural killer (NK) cells and Interferon (IFN)-gamma are crucial for anti-tumor immune surveillance.
- Previous research highlighted perforin's role in NK cell cytotoxicity and anti-tumor effects.
- TRAIL (Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand) is constitutively expressed on liver NK cells, mediating spontaneous cytotoxicity and anti-metastatic activity.
Purpose:
- To investigate the physiological role of TRAIL in tumor surveillance.
- To elucidate the regulation of TRAIL expression on NK cells.
- To explore the therapeutic potential of TRAIL in cancer treatment.
Summary:
- TRAIL expression on liver NK cells is regulated by endogenous IFN-gamma.
- IL-12 and alpha-Galactosylceramide induce TRAIL-mediated cytotoxicity and anti-tumor effects via IFN-gamma-activated NK cells.
- This study provides the first evidence for TRAIL's physiological function as a tumor suppressor.
Impact:
- Demonstrates TRAIL's critical role in NK cell-mediated anti-tumor immunity.
- Suggests TRAIL as a potential therapeutic agent for cancer, with preclinical studies showing efficacy and low toxicity.
- Advances understanding of the molecular mechanisms underlying immune surveillance against tumors.